Autism and Disruptive Behavior Trial
ASD, Child Behavior Problem
About this trial
This is an interventional treatment trial for ASD focused on measuring Autism spectrum disorder, Sequential Multiple Assignment Randomized Trial
Eligibility Criteria
Inclusion Criteria:
- Child is age 5 through 12 years 11 months
- Diagnosed with autism spectrum disorder (ASD) and receives care for ASD at the Children's Hospital of Philadelphia (CHOP) in Developmental and Behavioral Pediatrics (DBP) or Child Neurology, or in Department of Child and Adolescent Psychiatry and Behavioral Sciences (DCAPBS)
- Child exhibits disruptive behaviors characterized by tantrums, outbursts, self-injurious, or aggressive behaviors with a Clinical Global Impression severity (CGI-S) for the disruptive behavior of at least 4
- A caregiver completed Aberrant Behavior Checklist (ABC-2) Irritability subscale score is greater than 13
- A parent of the child who is involved in coordinating the child's care will also participate as a research subject.
Exclusion Criteria:
- Child requires crisis intervention or urgent psychiatric consultation
- Referring physician or psychologist will not be providing ongoing management of the child's behavioral challenges.
- Parent needs a different intervention or type of assistance than will be available through the study
- Families who live outside a 40 mile radius from the Children's Hospital of Philadelphia (CHOP -main)
Sites / Locations
- The Children's Hospital of Philadelphia
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Social Worker vs Autism Behavioral Health Navigation (ABHN)
Social work + ABHN vs Social work + ABHN + CAP
Phase 1: Families providing informed consent will then be randomized to social work consultation or to the Autism Behavioral Health Navigation (ABHN) intervention. Non-responders to ABHN will move to ABHN + Complex Autism Program (CAP).
At 3 months, children who are considered to be "responders" to their current treatment will continue; children who are "nonresponders" in the social work arm of the study will be randomized to either ABHN or ABHN+CAP. Children in the ABHN arm who are non-responders will receive ABHN + CAP